Gantofiban

CAS No. 183547-57-1

Gantofiban( —— )

Catalog No. M36175 CAS No. 183547-57-1

Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 192 In Stock
10MG 274 In Stock
25MG 430 In Stock
50MG 600 In Stock
100MG 820 In Stock
200MG 1097 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gantofiban
  • Note
    Research use only, not for human use.
  • Brief Description
    Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
  • Description
    Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    183547-57-1
  • Formula Weight
    447.48
  • Molecular Formula
    C21H29N5O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C[C@@H](CN2CCN(CC(OCC)=O)CC2)O1)C3=CC=C(C(NC(OC)=O)=N)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JK-273

    A small molecule inhibitor of α4 integrin-dependent cell migration that functions by interacting with γ-parvin.

  • Volociximab

    Volociximab (M200) is an IgG4 monoclonal antibody targeting the α5β1 integrin , with antiangiogenic, antitumor and anticancer activity, inhibits the growth of rabbit VX2 tumors and is used to study solid tumors.

  • ATN-161 trifluoroace...

    ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist that inhibits angiogenesis and growth of liver metastases in a murine model.The combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to control and single-agent therapy.